编号 |
产品名称 |
CAS号 |
规格 |
价格 |
|
| A-1419 |
甲磺酸马赛替尼对照品 ≥99%
AB 1010(Masitinib mesylate) ≥99% |
1048007-93-7 |
|
|
| A-1873 |
阿比特龙对照品 ≥100%
Abiraterone(CB 7598) ≥100% |
154229-19-3 |
|
|
| A-2141 |
ABT 199(GDC 0199) ≥98%
ABT 199(GDC 0199) ≥98% |
1257044-40-8 |
|
|
| A-1874 |
阿比特龙醋酸酯对照品 ≥100%
Abiraterone acetate(CB 7630;JNJ 212082) ≥100% |
154229-18-2 |
|
|
| A-1510 |
ABT 239 tartrate ≥99%
ABT 239 tartrate ≥99% |
460748-71-4 |
|
|
| A-1504 |
ABT 102 ≥99%
ABT 102 ≥99% |
808756-71-0 |
|
|
| A-1250 |
ABT 724 triHCl ≥99%
ABT 724 triHCl ≥99% |
587870-77-7 |
|
|
| A-1638 |
利尼伐尼对照品 ≥99%
ABT 869(Linifanib) ≥99% |
796967-16-3 |
|
|
| A-1593 |
ABT 888(Veliparib) ≥99%
ABT 888(Veliparib) ≥99% |
912444-00-9 |
|
|
| A-1188 |
Adenosine amine congener(ADAC) ≥98%
Adenosine amine congener(ADAC) ≥98% |
96760-69-9 |
|
|
| A-1696 |
AC 220 diHCl(Quizartinib diHCl) ≥98%
AC 220 diHCl(Quizartinib diHCl) ≥98% |
1132827-21-4 |
|
|
| A-1751 |
ADL 5859 ≥99%
ADL 5859 ≥99% |
850173-95-4 |
|
|
| A-2083 |
ADAMTS-5 inhibitor(Compound 12) ≥100%
ADAMTS-5 inhibitor(Compound 12) ≥100% |
929634-33-3 |
|
|
| A-1653 |
AEE 788(NVP-AEE 788) ≥98%
AEE 788(NVP-AEE 788) ≥98% |
497839-62-0 |
|
|
| A-1291 |
AEG 3482 ≥99%
AEG 3482 ≥99% |
63735-71-7 |
|
|
| A-1414 |
阿西替尼对照品 ≥99%
AG 013736(Axitinib) ≥99% |
319460-85-0 |
|
|
| A-1378 |
AG 490(Tyrphostin AG 490;Tyrphostin B42) ≥99%
AG 490(Tyrphostin AG 490;Tyrphostin B42) ≥99% |
133550-30-8 |
|
|
| A-1529 |
AG 014699(PF 01367338) ≥98%
AG 014699(PF 01367338) ≥98% |
459868-92-9 |
|
|
| A-1571 |
芦平曲韦对照品 ≥98%
AG 7088(Rupintrivir;Ruprintrivir) ≥98% |
223537-30-2 |
|
|
| A-2122 |
AGI 5198 ≥100%
AGI 5198 ≥100% |
1355326-35-0 |
|
|
